Rafferty Asset Management, LLC Second Sight Medical Products Inc Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$1.16 - $1.83 $39,422 - $62,192
-33,985 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$1.63 - $3.41 $11,167 - $23,361
6,851 Added 25.25%
33,985 $55,000
Q3 2021

Nov 10, 2021
BUY
$3.11 - $4.75 $84,386 - $128,886
27,134 New
27,134 $87,000

About SECOND SIGHT MEDICAL PRODUCTS INC

EYES Quotes by TradingView
  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email